Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

New Swiss hedge fund endorses the wisdom of following 'the vital few' – but not blindly

Monday, September 12, 2011

amb
Athanasios Ladopoulos
Benedicte Gravrand, Opalesque Geneva:

We heard last week that a fund boutique in Zurich called Swiss Investment Managers (SIM) would be launching the "Directors' Dealings Fund" (DDF) this month. DDF is meant to be the first hedge fund investing solely in the reported share dealings of company directors and senior corporate executives in their own firms.

This might be a good period for such a fund to start, as apparently, more executives at European companies are buying their stock than at any time since October 2008. "Directors have a good ability in timing the market," Chris Montagu, a London-based quantitative strategist at Citigroup, reported earlier this month according to Bloomberg. "One can conclude that, at this juncture, directors see current valuations as an attractive entry point." And insiders of financial companies bought more stock in August than in any month in the last three years, said Hedgeye on CNN, just as bank stocks are heading down following news that the U.S. may sue the major banks for their mortgage-backed securities selling before the ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other Voices: Same day reporting and the evolving role of fund administrators[more]

    By: Scott Price, Head of Business Development and Client Management for North America, Maitland Ernst & Young’s latest glob

  2. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  3. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  4. Cowen Group, Inc. to acquire Conifer Securities[more]

    Cowen Group, Inc. and Conifer Securities, LLC had announced the signing of a definitive agreement under which Cowen will acquire Conifer Securities, the prime services division of Conifer Financial Services LLC. The transaction, the terms of which have not yet been disclosed, was approved by the boa

  5. Cargill’s Black River Asset to shut down four hedge funds[more]

    Komfie Manalo, Opalesque Asia: Cargill Inc.’s $7.4 billion Black River Asset Management said it was closing four hedge funds with a combined $ 1 billion in assets and start returning investors money over the next several months, various media said. The hedge funds represent 15% of Black River’

 

banner